Consistent with what we observed in adenocarcinoma cell lines (Fig. 5c), genetic (KO) or pharmacological inhibition of CDC7 again induced the activation of the proteasome (Supplementary Fig. s6g). This evidence concerns the gene CDC7 and adenocarcinoma.